Mirador Therapeutics

A new vantage point on inflammation and fibrosis

San Diego, United States · Founded 2024 · $650.0M raised

Employees
11–50
Founded
2024
Business Model
B2B
Total Funding
$650.0M
Last Round
$250.0M Series BOct 2025
Rounds
2

About

Mirador Therapeutics is a clinical-stage precision medicine company developing targeted therapies for immune-mediated inflammatory and fibrotic diseases. Using Mirador360™, an integrated platform with multi-modal data, AI, and advanced analytics, it identifies novel targets and optimal therapies to accelerate pipeline development.

Summary

Mirador Therapeutics is a Biotech company based in San Diego, United States, founded in 2024. It has raised $650.0M in total across 2 rounds, most recently a $250.0M Series B round in Oct 2025. Investors include ARCH Venture Partners, OrbiMed and Innovation Endeavors.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BOct 2025
$250.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mirador Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mirador-therapeutics"><img src="https://indexed.vc/api/badge/company/mirador-therapeutics" alt="Mirador Therapeutics on Indexed.vc" width="260" height="76" /></a>